Company Description
Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched Guardant360®, Guardant360 CDx, Guardant360 TissueNext™, Guardant360 Response™, and GuardantOMNI® tests for advanced stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. The Guardant Health screening portfolio, including the Shield™ test, aims to address the needs of individuals eligible for cancer screening.
Job Description
Reporting to the Spain Country Manager, the Senior Key Account Manager is an experienced professional responsible for driving and overseeing the strategic expansion of Guardant Health’s business in Spain. This senior role demands an in-depth expertise in precision medicine in oncology, with a particular focus on the integration of biomarkers and advanced diagnostic tests in clinical practice. The individual will execute the French national strategy, collaborating closely with the French team to foster growth. This role involves establishing and nurturing relationships with key customers and accounts, supporting with clinical pathway transformation where required.
Essential Duties and Responsibilities:
- Lead business expansion and strategic collaborations with:
- National hospitals and private cancer centres and clinics
- Key Opinion Leaders (KOLs), treating physicians, oncologists, respiratory physician, nurses and hospital, and local heath economy stakeholders
- Cultivate productive relationships with thought leaders and decision-makers to advocate for and enhance understanding of the benefits of tumour profiling with liquid biopsy assays.
- Develop and implement comprehensive account and business plans for the territory, aligning with broader company objectives.
- Coordinate with national and international colleagues to achieve country-specific goals and objectives.
- Continuously analyse the competitive landscape, providing strategic feedback to Guardant Health leadership.
- Track and report performance against objectives, adapting plans to ensure sales targets are met.
- Embody and represent Guardant Health’s company culture to both external and internal stakeholders.
Qualifications
Experience Profile:
- Minimum of 7-10 years of sales and account management experience working with national hospitals and private cancer centres and clinics in Spain.
- Deep expertise in oncology therapies and companion diagnostics, with a strong understanding of precision oncology, clinical medicine and cancer genomics
- Proven track record in commercialization of oncology pharmaceutical, diagnostic, and/or laboratory-developed tests.
Skills and Knowledge:
- Demonstrated ability to lead a consultative selling process within local health economies, especially in oncology hospital settings.
- Exceptional strategic sales, negotiation, and key account planning skills.
- Superior listening and problem-solving abilities.
- Excellent oral, verbal, written communication, and presentation skills.
- High proficiency with Microsoft Office Suite and salesforce.com.
- Strong cross-functional collaboration skills to achieve organisational goals.
- Ability to operate effectively with minimal supervision.
- Strong problem-solving, decision-making, technical learning, and administrative skills.
- Proven capability to manage business in a healthcare environment.
- Awareness of the payor and reimbursement landscape in the oncology and diagnostic sectors in Spain.
- Extensive clinical knowledge of oncology, haematology, chemotherapeutics, and targeted agents.
Education:
- B.Sc. in Biology, Biomedical Sciences, Genetics or Life Sciences. Advanced degree strongly desired.
Other Details:
- Frequent travel ( > 50%) throughout the territory as required.
- Attendance at national and international congresses and meetings.
- Working from home when not traveling.
- Valid French driver’s license required.
Additional Information
Employee may be required to lift routine office supplies and use office equipment. Majority of the work is performed in a desk/office environment; however, there may be exposure to high noise levels, fumes, and biohazard material in the laboratory environment. Ability to sit for extended periods of time.
Guardant Health is committed to providing reasonable accommodations in our hiring processes for candidates with disabilities, long-term conditions, mental health conditions, or sincerely held religious beliefs. If you need support, please reach out to [email protected]
Guardant Health is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.
All your information will be kept confidential according to EEO guidelines.
To learn more about the information collected when you apply for a position at Guardant Health, Inc. and how it is used, please review our Privacy Notice for Job Applicants.
Please visit our career page at: http://www.guardanthealth.com/jobs/
#LI-MT1
What We Do
Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The Guardant Health oncology platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has commercially launched liquid biopsy-based Guardant360®, Guardant360 CDx, and GuardantOMNI® tests for advanced stage cancer patients, and Guardant Reveal™ for early-stage cancer patients. These tests fuel development of its LUNAR screening program, which aims to address the needs of asymptomatic individuals eligible for cancer screening and individuals at a higher risk for developing cancer with early detection.